PL BioScience

About:

We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate

Website: https://www.pl-bioscience.com/

Top Investors: Avant Bio, better ventures, LePure Biotech, Brightlands Venture Partners, TechVision Fund

Description:

STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.

Total Funding Amount:

11.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Aachen, Nordrhein-Westfalen, Germany

Founded Date:

2015-01-01

Contact Email:

info(AT)pl-bioscience.com

Founders:

Hatim Hemeda

Number of Employees:

1-10

Last Funding Date:

2024-08-08

IPO Status:

Private

Industries: